Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
KEGG_2019_Mouse,Spliceosome,19/132,9.06120838758506e-05,0.0250995472336106,0,0,2.9715549936788874,27.66197656014469,RBM17;SF3B2;HNRNPA3;NCBP1;HNRNPU;THOC3;USP39;LSM4;CDC40;PRPF4;SART1;PRPF6;HNRNPK;PUF60;U2AF2;TRA2B;HNRNPC;SRSF9;RBM22
KEGG_2019_Mouse,ErbB signaling pathway,13/84,0.0005575426606114316,0.0669495838969873,0,0,3.224930893773858,24.161090462628582,CAMK2D;CDKN1B;ARAF;PIK3CD;EREG;PIK3CA;ERBB2;GRB2;RAF1;SOS2;NCK1;PAK4;MAPK3
KEGG_2019_Mouse,RNA transport,20/167,0.0007250857461767581,0.0669495838969873,0,0,2.4023908716826337,17.367413673749045,NDC1;EIF2B4;EIF2B3;SEC13;UBE2I;NCBP1;FMR1;THOC3;UPF3A;NUP93;NUP62;EIF3G;EIF4EBP2;NUP88;EIF2B1;RPP14;RAE1;EIF4E;EIF4G2;EIF3B
KEGG_2019_Mouse,N-Glycan biosynthesis,9/50,0.0013019050563329,0.0901569251510567,0,0,3.858018803651724,25.63239398150003,GANAB;MAN2A1;SRD5A3;MGAT4B;ALG14;ALG2;STT3A;DOLK;STT3B
KEGG_2019_Mouse,Glioma,11/75,0.0022620233480199,0.0957921560900755,0,0,3.0227232975746268,18.412905605208053,PDGFRA;CAMK2D;PIK3CA;ARAF;MDM2;PIK3CD;GRB2;CALML4;RAF1;SOS2;MAPK3
KEGG_2019_Mouse,Choline metabolism in cancer,13/99,0.002612863648621,0.0957921560900755,0,0,2.660323842642904,15.821766537546324,PDGFRA;CHKB;PIK3CD;PLA2G4A;PLD2;PIK3CA;RHEB;GRB2;PIP5K1C;RAF1;PLPP2;SOS2;MAPK3
KEGG_2019_Mouse,Protein processing in endoplasmic reticulum,18/163,0.0032269148836069,0.0957921560900755,0,0,2.1880913064594463,12.551392243508166,MBTPS1;TRAM1;SEC13;SSR4;SSR2;CUL1;SYVN1;UBE2G1;PDIA4;DNAJA1;GANAB;DNAJB11;DNAJA2;STT3A;STT3B;P4HB;SEC24D;RNF185
KEGG_2019_Mouse,GnRH signaling pathway,12/90,0.0033058491186009,0.0957921560900755,0,0,2.706169647346118,15.457808589721148,MAP3K3;MAPK11;CAMK2D;GNAS;PLA2G4A;GNRH1;GRB2;CALML4;RAF1;SOS2;PLD2;MAPK3
KEGG_2019_Mouse,Chagas disease (American trypanosomiasis),13/103,0.0037081542697993,0.0957921560900755,0,0,2.5415472481827623,14.225601700064445,ACE;PIK3CD;PPP2R2A;TNFRSF1A;C3;PPP2CB;MAPK11;PIK3CA;GNAS;CCL2;TLR6;TLR2;MAPK3
KEGG_2019_Mouse,Endometrial cancer,9/58,0.0037606174419411,0.0957921560900755,0,0,3.226770037623988,18.01561251745605,PIK3CA;ERBB2;ARAF;CTNNA1;PIK3CD;GRB2;RAF1;SOS2;MAPK3
KEGG_2019_Mouse,Acute myeloid leukemia,10/69,0.003851251587278,0.0957921560900755,0,0,2.978817508332412,16.560310252360644,CCNA1;CSF1R;PIK3CA;ZBTB16;ARAF;PIK3CD;GRB2;RAF1;SOS2;MAPK3
KEGG_2019_Mouse,mTOR signaling pathway,17/154,0.0041498406970429,0.0957921560900755,0,0,2.186083455444324,11.98997986201531,SEC13;CAB39L;PIK3CD;SLC3A2;CASTOR1;TNFRSF1A;PIK3CA;RHEB;GRB2;LAMTOR2;RAF1;LAMTOR4;ATP6V1E2;SOS2;EIF4E;WNT4;MAPK3
KEGG_2019_Mouse,Prostate cancer,12/97,0.0060977515453225,0.1208859090036185,0,0,2.4823858955346845,12.65975890767296,PDGFRA;CDKN1B;PIK3CA;ERBB2;ARAF;MDM2;PIK3CD;GRB2;RAF1;SOS2;FGFR2;MAPK3
KEGG_2019_Mouse,Citrate cycle (TCA cycle),6/32,0.0067058761474411,0.1208859090036185,0,0,4.047782301264196,20.25822388056327,SUCLA2;OGDH;DLST;DLAT;ACO2;SDHB
KEGG_2019_Mouse,Fc gamma R-mediated phagocytosis,11/87,0.0071920250899029,0.1208859090036185,0,0,2.5438310094265515,12.553252731063798,MARCKS;PTPRC;NCF1;PIK3CA;PIK3CD;PLA2G4A;PIP5K1C;RAF1;PLPP2;PLD2;MAPK3
KEGG_2019_Mouse,Central carbon metabolism in cancer,9/64,0.0072906922096298,0.1208859090036185,0,0,2.873844591163027,14.1426398064216,PDGFRA;PIK3CA;NTRK3;ERBB2;PIK3CD;RAF1;FGFR2;SIRT3;MAPK3
KEGG_2019_Mouse,Platelet activation,14/125,0.0077641497203282,0.1208859090036185,0,0,2.218828744553721,10.77959885437404,FGG;PIK3CD;PLA2G4A;PRKCZ;COL1A1;APBB1IP;MAPK11;STIM1;PIK3CA;GNAS;ORAI1;ARHGEF1;FERMT3;MAPK3
KEGG_2019_Mouse,Ubiquitin mediated proteolysis,15/138,0.007855402029116,0.1208859090036185,0,0,2.146021741116288,10.400809882841166,UBE2I;SMURF1;CUL3;CUL1;SYVN1;UBE2G1;UBE3B;RCHY1;HERC4;HERC3;UBE2S;CDC26;UBA3;MDM2;UBA1
KEGG_2019_Mouse,T cell receptor signaling pathway,12/101,0.0083804424151143,0.122178028894035,0,0,2.370314417901992,11.334498835647384,ZAP70;MAPK11;PTPRC;PIK3CA;GRAP2;PIK3CD;GRB2;RAF1;SOS2;NCK1;PAK4;MAPK3
KEGG_2019_Mouse,"Valine, leucine and isoleucine degradation",8/56,0.0101403656383158,0.140444064090675,0,0,2.9254263565891474,13.431308827390316,MCCC2;ALDH3A2;ALDH6A1;HIBADH;OXCT1;AGXT2;BCKDHB;ALDH9A1
KEGG_2019_Mouse,Proteasome,7/46,0.0112708726910614,0.144686997760406,0,0,3.149032504051092,14.12509084950413,PSMA3;PSMD11;PSMA1;PSMD13;PSMD2;PSMA7;PSMB10
KEGG_2019_Mouse,Endocytosis,24/269,0.0114913861037145,0.144686997760406,0,0,1.7271896860727294,7.713901271829776,PDGFRA;SMURF1;AGAP1;CLTA;CXCR4;AP2B1;PRKCZ;RAB11A;ARFGAP1;RAB11B;PLD2;ARFGAP2;EHD1;ACAP3;EHD4;CAPZB;CHMP1B;GRK6;MDM2;MVB12A;PIP5K1C;FOLR2;FGFR2;SNX6
KEGG_2019_Mouse,Human papillomavirus infection,30/360,0.0129340477145202,0.1531969654995622,0,0,1.604679271345938,6.976972305877671,CDKN1B;MAML1;PXN;PIK3CD;PPP2R2A;PRKCZ;PPP2CB;TBK1;ATP6V1E2;IKBKE;ATP6V0A1;JAK1;WNT4;MAPK3;HES6;TBP;TNFRSF1A;COL1A1;CCNA1;PIK3CA;NFX1;COL4A1;RHEB;GNAS;MDM2;TBPL1;GRB2;RAF1;SOS2;IRF9
KEGG_2019_Mouse,Hepatitis C,16/160,0.0132733832923808,0.1531969654995622,0,0,1.9549099239820888,8.44910994952419,ARAF;PIK3CD;NR1H3;PPP2R2A;TNFRSF1A;PPP2CB;TBK1;YWHAQ;PIK3CA;GRB2;RAF1;IKBKE;SOS2;IRF9;JAK1;MAPK3
KEGG_2019_Mouse,Neurotrophin signaling pathway,13/121,0.0139980987680505,0.15509893435,0,0,2.115931118033922,9.032558192340616,MAP3K3;CAMK2D;BDNF;NTRK3;PIK3CD;CALML4;MAPK11;PIK3CA;ARHGDIA;GRB2;RAF1;SOS2;MAPK3
KEGG_2019_Mouse,Prolactin signaling pathway,9/72,0.0153754368409071,0.1638075386512035,0,0,2.5078478318701785,10.470224706101922,MAPK11;CISH;PIK3CA;PIK3CD;GRB2;RAF1;PRLR;SOS2;MAPK3
KEGG_2019_Mouse,One carbon pool by folate,4/19,0.0172572768627953,0.1770468774442339,0,0,4.6714859437751,18.963997052692164,MTHFD1L;MTHFD1;SHMT1;GART
KEGG_2019_Mouse,Ubiquinone and other terpenoid-quinone biosynthesis,3/11,0.0188332564776098,0.1863147158677831,0,0,6.565625,26.07952266477048,NQO1;GGCX;COQ5
KEGG_2019_Mouse,Chronic myeloid leukemia,9/76,0.0212801807012827,0.2021678601898953,0,0,2.3576252814141583,9.0768081131674,CDKN1B;PIK3CA;ARAF;MDM2;PIK3CD;GRB2;RAF1;SOS2;MAPK3
KEGG_2019_Mouse,Thyroid hormone signaling pathway,12/115,0.0218954361216493,0.2021678601898953,0,0,2.046612819885236,7.821083942198128,MED24;HDAC3;PIK3CA;RHEB;SIN3A;NCOA3;MDM2;PIK3CD;RAF1;MED16;WNT4;MAPK3
KEGG_2019_Mouse,Viral carcinogenesis,20/229,0.0242368897268897,0.2165683372370469,0,0,1.6841385084193423,6.2647922075573295,RANBP1;SP100;CDKN1B;TBP;HDAC3;PXN;PIK3CD;SND1;C3;CCNA1;HNRNPK;YWHAQ;PIK3CA;MDM2;TBPL1;GRB2;MAD1L1;IRF9;JAK1;MAPK3
KEGG_2019_Mouse,Non-small cell lung cancer,8/66,0.0256163517851126,0.2176324114106737,0,0,2.4197594226142742,8.86726742161656,PIK3CA;ERBB2;ARAF;PIK3CD;GRB2;RAF1;SOS2;MAPK3
KEGG_2019_Mouse,FoxO signaling pathway,13/132,0.0268291363555227,0.2176324114106737,0,0,1.919217780570172,6.944241986177298,CDKN1B;PLK2;ARAF;PIK3CD;SOD2;MAPK11;PIK3CA;CCNG2;MDM2;GRB2;RAF1;SOS2;MAPK3
KEGG_2019_Mouse,Vasopressin-regulated water reabsorption,6/43,0.0273202977007363,0.2176324114106737,0,0,2.8427313106978844,10.234189047869304,DCTN4;ARHGDIA;GNAS;DYNLL2;RAB11A;RAB11B
KEGG_2019_Mouse,Proteoglycans in cancer,18/203,0.0274986801421428,0.2176324114106737,0,0,1.7113361248572516,6.149887053562578,CAMK2D;SDC2;PXN;ARAF;PIK3CD;COL1A1;MAPK11;PIK3CA;ERBB2;MDM2;HCLS1;GRB2;ARHGEF1;RAF1;SOS2;TLR2;WNT4;MAPK3
KEGG_2019_Mouse,Fc epsilon RI signaling pathway,8/68,0.0300251920098445,0.2247831942358635,0,0,2.338852713178295,8.19935926287381,MAPK11;PIK3CA;PIK3CD;PLA2G4A;GRB2;RAF1;SOS2;MAPK3
KEGG_2019_Mouse,Renal cell carcinoma,8/68,0.0300251920098445,0.2247831942358635,0,0,2.338852713178295,8.19935926287381,PIK3CA;ARAF;PIK3CD;GRB2;RAF1;SOS2;PAK4;MAPK3
KEGG_2019_Mouse,Phospholipase D signaling pathway,14/149,0.0315730018032982,0.2301505657766737,0,0,1.822042060769844,6.295980517138055,PDGFRA;PIK3CD;PLA2G4A;PLD2;PIK3CA;RHEB;GNAS;GRB2;PIP5K1C;RAF1;PLPP2;SOS2;RAPGEF4;MAPK3
KEGG_2019_Mouse,Terpenoid backbone biosynthesis,4/23,0.033241756786092,0.2361017084550641,0,0,3.6872347690356566,12.551157109382425,FDPS;IDI1;PDSS1;DHDDS
KEGG_2019_Mouse,VEGF signaling pathway,7/58,0.0363509484616996,0.2470084243662153,0,0,2.4065529557547927,7.976603959958225,MAPK11;PIK3CA;PXN;PIK3CD;PLA2G4A;RAF1;MAPK3
KEGG_2019_Mouse,Lysosome,12/124,0.0365608137148549,0.2470084243662153,0,0,1.8812525010004,6.224647406365625,SCARB2;ABCA2;NPC1;CTSZ;LAPTM5;AP1S1;CLTA;ACP2;AP3S2;AP3S1;MCOLN1;ATP6V0A1
KEGG_2019_Mouse,Histidine metabolism,4/24,0.038233809705052,0.2484128276101287,0,0,3.502687673772011,11.432895455489504,ALDH3A2;ALDH1A3;HDC;ALDH9A1
KEGG_2019_Mouse,Insulin signaling pathway,13/139,0.0385622800983232,0.2484128276101287,0,0,1.811919596499036,5.898669239767012,PTPN1;ARAF;PIK3CD;CALML4;PRKCZ;PIK3CA;PRKAR2B;RHEB;GRB2;RAF1;SOS2;EIF4E;MAPK3
KEGG_2019_Mouse,B cell receptor signaling pathway,8/72,0.0403471473075657,0.2540036319135389,0,0,2.192209302325581,7.03750612089865,CD79A;PIK3CA;PIK3CD;GRB2;RAF1;PIK3AP1;SOS2;MAPK3
KEGG_2019_Mouse,Nicotinate and nicotinamide metabolism,5/36,0.04317514904229,0.2657670285492075,0,0,2.825722664432342,8.879805789104198,PNP;NAMPT;NT5M;NADSYN1;NADK
KEGG_2019_Mouse,Glycerolipid metabolism,7/61,0.0459698541002292,0.2701659611859023,0,0,2.2724941484235166,6.998758037649822,ALDH3A2;PLPP5;DGAT1;GLYCTK;AKR1A1;PLPP2;ALDH9A1
KEGG_2019_Mouse,Long-term depression,7/61,0.0459698541002292,0.2701659611859023,0,0,2.2724941484235166,6.998758037649822,PPP2CB;ARAF;GNAS;PLA2G4A;RAF1;GRIA3;MAPK3
KEGG_2019_Mouse,AGE-RAGE signaling pathway in diabetic complications,10/101,0.0468157622271599,0.2701659611859023,0,0,1.9280439970095145,5.902774820494881,COL1A1;MAPK11;CDKN1B;PIK3CA;COL4A1;PIK3CD;CCL2;PRKCZ;F3;MAPK3
KEGG_2019_Mouse,MAPK signaling pathway,23/294,0.0494981939621754,0.2798163209698489,0,0,1.4929262688853304,4.487466287466368,MAP3K3;PDGFRA;CSF1R;PTPRR;DUSP3;ANGPT2;MAX;BDNF;ARAF;PLA2G4A;ECSIT;EREG;TNFRSF1A;MAPK11;PPM1B;TAOK2;ERBB2;GRB2;TEK;RAF1;SOS2;FGFR2;MAPK3
KEGG_2019_Mouse,PI3K-Akt signaling pathway,27/357,0.0505682312865969,0.2801480013277468,0,0,1.44010847107438,4.297905430187432,CSF1R;CDKN1B;PIK3CD;PPP2R2A;PPP2CB;YWHAQ;ERBB2;EIF4E;JAK1;MAPK3;PDGFRA;ANGPT2;BDNF;PRLR;EREG;COL1A1;PIK3CA;COL4A1;RHEB;MDM2;GRB2;TEK;RAF1;PIK3AP1;SOS2;FGFR2;TLR2
KEGG_2019_Mouse,Progesterone-mediated oocyte maturation,9/90,0.0545199058024505,0.2939302221159686,0,0,1.9486861162838816,5.669096993257834,CCNA1;MAPK11;PIK3CA;CDC26;ARAF;PIK3CD;RAF1;MAD1L1;MAPK3
KEGG_2019_Mouse,HIF-1 signaling pathway,10/104,0.0551782366427089,0.2939302221159686,0,0,1.866213241855208,5.40676812238129,CAMK2D;CDKN1B;ANGPT2;PIK3CA;ERBB2;HMOX1;PIK3CD;TEK;EIF4E;MAPK3
KEGG_2019_Mouse,Huntington disease,16/192,0.0577097251699605,0.3016149787184732,0,0,1.596745335264548,4.55444393957577,HIP1;TBP;NDUFB10;BDNF;DCTN4;COX4I2;CLTA;AP2B1;COX6A1;COX6B2;SOD2;SDHB;SIN3A;POLR2C;TBPL1;NDUFV3
KEGG_2019_Mouse,Hepatitis B,14/163,0.0593156040384692,0.3042670799751109,0,0,1.6496129481859103,4.659963360039054,ARAF;PIK3CD;CCNA1;MAPK11;TBK1;YWHAQ;PIK3CA;GRB2;RAF1;IKBKE;SOS2;JAK1;TLR2;MAPK3
KEGG_2019_Mouse,Rap1 signaling pathway,17/209,0.0619750999849065,0.3078625354619749,0,0,1.555293347404628,4.32530592971249,PDGFRA;CSF1R;ANGPT2;PIK3CD;CALML4;PRKCZ;APBB1IP;MAPK11;PIK3CA;CNR1;ID1;GNAS;TEK;RAF1;FGFR2;RAPGEF4;MAPK3
KEGG_2019_Mouse,RNA polymerase,4/28,0.0622393573497133,0.3078625354619749,0,0,2.9182885387704665,8.103409425304338,POLR3A;POLR3GL;POLR2C;POLR3K
KEGG_2019_Mouse,Glycosaminoglycan biosynthesis,6/53,0.0656541784625252,0.315157157227986,0,0,2.236709535945001,6.091351934684376,EXT1;EXT2;B3GAT3;CSGALNACT2;B3GNT2;B4GALT7
KEGG_2019_Mouse,Riboflavin metabolism,2/8,0.0659895852679537,0.315157157227986,0,0,5.831329016342893,15.851058780811051,RFK;ACP2
KEGG_2019_Mouse,Signaling pathways regulating pluripotency of stem cells,12/137,0.0683001054535372,0.3176298760020907,0,0,1.684436974789916,4.520766014991957,MAPK11;PIK3CA;ID1;PCGF3;PIK3CD;GRB2;TCF3;RAF1;FGFR2;WNT4;JAK1;MAPK3
KEGG_2019_Mouse,Bladder cancer,5/41,0.0690112475416902,0.3176298760020907,0,0,2.432616986188415,6.50356692031998,ERBB2;ARAF;MDM2;RAF1;MAPK3
KEGG_2019_Mouse,Cell cycle,11/123,0.0699473734156228,0.3176298760020907,0,0,1.722872801172708,4.582862546173531,CDKN1C;ZBTB17;CCNA1;ORC6;CDKN1B;YWHAQ;CDC26;CUL1;MDM2;MCM5;MAD1L1
KEGG_2019_Mouse,Influenza A,14/168,0.0723208418377552,0.3231108578880356,0,0,1.5956288800068033,4.191147304622873,CPSF4;FDPS;PIK3CD;TNFRSF1A;MAPK11;TBK1;PIK3CA;CCL2;RAF1;IKBKE;RAE1;IRF9;JAK1;MAPK3
KEGG_2019_Mouse,Insulin resistance,10/110,0.0747070176965487,0.3284737127292698,0,0,1.753681267474371,4.549367055873812,PTPA;PTPN1;PIK3CA;GFPT2;MLX;PIK3CD;NR1H3;PRKCZ;SLC27A4;TNFRSF1A
KEGG_2019_Mouse,Steroid biosynthesis,3/19,0.0803571628521423,0.3436993651605876,0,0,3.2814236111111112,8.273368181778572,EBP;SOAT1;FDFT1
KEGG_2019_Mouse,Apoptosis,12/141,0.0808473316974451,0.3436993651605876,0,0,1.6318589451284389,4.104439700713114,DFFB;BECN1;PARP4;PIK3CA;CASP6;CTSZ;LMNA;PRF1;PIK3CD;RAF1;TNFRSF1A;MAPK3
KEGG_2019_Mouse,Ras signaling pathway,18/233,0.0825951016478135,0.3436993651605876,0,0,1.4701867016049788,3.666358803756153,PDGFRA;CSF1R;ANGPT2;BDNF;PIK3CD;PLA2G4A;CALML4;PLD2;ZAP70;TBK1;PIK3CA;GRB2;TEK;RAF1;SOS2;FGFR2;PAK4;MAPK3
KEGG_2019_Mouse,Glyoxylate and dicarboxylate metabolism,4/31,0.0843738513751623,0.3436993651605876,0,0,2.5936223526584974,6.412725413696262,ACSS2;SHMT1;GLYCTK;ACO2
KEGG_2019_Mouse,Propanoate metabolism,4/31,0.0843738513751623,0.3436993651605876,0,0,2.5936223526584974,6.412725413696262,ALDH6A1;ACSS2;SUCLA2;BCKDHB
KEGG_2019_Mouse,Fluid shear stress and atherosclerosis,12/143,0.0876313275000549,0.3475775104941517,0,0,1.6067740073128487,3.911878871670886,NQO1;MAPK11;NCF1;PIK3CA;GSTO1;SDC2;HMOX1;PIK3CD;CCL2;CALML4;PRKCZ;TNFRSF1A
KEGG_2019_Mouse,Toll-like receptor signaling pathway,9/99,0.0878354719660311,0.3475775104941517,0,0,1.7529795158286778,4.263754285721905,MAPK11;TBK1;PIK3CA;TOLLIP;PIK3CD;TLR6;IKBKE;TLR2;MAPK3
KEGG_2019_Mouse,beta-Alanine metabolism,4/32,0.0924989935926176,0.3574369923959255,0,0,2.5008605851979344,5.953442459066789,ALDH3A2;ALDH1A3;ALDH6A1;ALDH9A1
KEGG_2019_Mouse,Leukocyte transendothelial migration,10/115,0.0939085360917589,0.3574369923959255,0,0,1.6697288421426353,3.949633358463226,MAPK11;NCF1;PIK3CA;PXN;CTNNA1;PIK3CD;CXCR4;JAM2;RAPGEF4;JAM3
KEGG_2019_Mouse,Melanoma,7/72,0.0941981965519948,0.3574369923959255,0,0,1.8868172719473837,4.45733078714372,PDGFRA;PIK3CA;ARAF;MDM2;PIK3CD;RAF1;MAPK3
KEGG_2019_Mouse,Relaxin signaling pathway,11/131,0.098603396457562,0.3626543125441758,0,0,1.6073305348258706,3.7236215941774566,COL1A1;MAPK11;PIK3CA;COL4A1;GNAS;PIK3CD;GRB2;RAF1;PRKCZ;SOS2;MAPK3
KEGG_2019_Mouse,Lysine degradation,6/59,0.0987468045386917,0.3626543125441758,0,0,1.9828664529353024,4.590724945999249,ALDH3A2;GCDH;KMT5C;DLST;EZH1;ALDH9A1
KEGG_2019_Mouse,Human cytomegalovirus infection,19/255,0.0995008222142865,0.3626543125441758,0,0,1.41351392251816,3.2618097039169074,PDGFRA;PXN;CXCR4;PIK3CD;CALML4;TNFRSF1A;MAPK11;TBK1;PIK3CA;RHEB;GNAS;MDM2;CCL2;GRB2;ARHGEF1;RAF1;SOS2;JAK1;MAPK3
KEGG_2019_Mouse,Colorectal cancer,8/88,0.1036448880109463,0.3728523893380797,0,0,1.752279069767442,3.972039492433516,PIK3CA;ARAF;PIK3CD;GRB2;RAF1;SOS2;EREG;MAPK3
KEGG_2019_Mouse,Natural killer cell mediated cytotoxicity,10/118,0.1067123023301623,0.3789654839160895,0,0,1.6230886058472265,3.631853625589209,ZAP70;PIK3CA;ARAF;PRF1;PIK3CD;GRB2;RAF1;HCST;SOS2;MAPK3
KEGG_2019_Mouse,Ether lipid metabolism,5/47,0.1090427868378443,0.3823398981529479,0,0,2.084437671172365,4.619145008268133,PLA2G4A;PLA2G7;PLPP2;PLD3;PLD2
KEGG_2019_Mouse,Pancreatic cancer,7/75,0.1109035555210636,0.3840035609916828,0,0,1.80328832276405,3.965601116090705,PIK3CA;ERBB2;ARAF;PIK3CD;RAF1;JAK1;MAPK3
KEGG_2019_Mouse,Gastric cancer,12/150,0.1140663149925525,0.3900786327523092,0,0,1.5247026346770591,3.310091743345277,CDKN1B;PIK3CA;ERBB2;ARAF;CTNNA1;PIK3CD;GRB2;RAF1;SOS2;FGFR2;WNT4;MAPK3
KEGG_2019_Mouse,Transcriptional misregulation in cancer,14/183,0.1218717460889328,0.4116887032516388,0,0,1.4528426168348454,3.05792287098413,CSF1R;ZBTB17;SS18;CDKN1B;LDB1;MAX;ZBTB16;MLF1;CCNA1;EWSR1;SIN3A;MDM2;TCF3;GRIA3
KEGG_2019_Mouse,Primary immunodeficiency,4/36,0.1284348111703939,0.4286318396891461,0,0,2.187789620018536,4.490074605099576,CD79A;ZAP70;PTPRC;ORAI1
KEGG_2019_Mouse,Sphingolipid signaling pathway,10/124,0.1351491968169066,0.445670565693847,0,0,1.5371723810925262,3.076459833260046,PPP2CB;MAPK11;PIK3CA;PIK3CD;PPP2R2A;RAF1;PRKCZ;PLD2;TNFRSF1A;MAPK3
KEGG_2019_Mouse,Hepatocellular carcinoma,13/171,0.1369117359260525,0.44617118648843,0,0,1.4424878741275289,2.86827004244293,NQO1;SMARCD2;GSTO1;ACTL6A;ARAF;PIK3CD;PIK3CA;HMOX1;GRB2;RAF1;SOS2;WNT4;MAPK3
KEGG_2019_Mouse,AMPK signaling pathway,10/126,0.1454407027373734,0.460062752715411,0,0,1.5105087251341711,2.9122409086626857,CCNA1;PPP2CB;EEF2K;PIK3CA;RHEB;CAB39L;PIK3CD;PPP2R2A;ELAVL1;RAB11B
KEGG_2019_Mouse,Aldosterone-regulated sodium reabsorption,4/38,0.1482742982455957,0.460062752715411,0,0,2.058878046121136,3.929762725691908,PIK3CA;SCNN1A;PIK3CD;MAPK3
KEGG_2019_Mouse,Pyruvate metabolism,4/38,0.1482742982455957,0.460062752715411,0,0,2.058878046121136,3.929762725691908,ALDH3A2;ACSS2;DLAT;ALDH9A1
KEGG_2019_Mouse,C-type lectin receptor signaling pathway,9/112,0.1531795321499142,0.460062752715411,0,0,1.530672018224223,2.871762091500889,MAPK11;PIK3CA;MDM2;PIK3CD;CALML4;RAF1;IKBKE;IRF9;MAPK3
KEGG_2019_Mouse,Glycolysis / Gluconeogenesis,6/67,0.1540209163401101,0.460062752715411,0,0,1.7220877665646832,3.2214525242248557,ALDH3A2;ALDH1A3;ACSS2;AKR1A1;DLAT;ALDH9A1
KEGG_2019_Mouse,Leishmaniasis,6/67,0.1540209163401101,0.460062752715411,0,0,1.7220877665646832,3.2214525242248557,C3;MAPK11;NCF1;JAK1;TLR2;MAPK3
KEGG_2019_Mouse,Non-homologous end-joining,2/13,0.1540993284326664,0.460062752715411,0,0,3.179883945841393,5.946885065425937,XRCC6;XRCC4
KEGG_2019_Mouse,Glycerophospholipid metabolism,8/97,0.1548896441659969,0.460062752715411,0,0,1.5743297622158348,2.936191740416968,PTDSS2;PLPP5;PTDSS1;CHKB;PLA2G4A;PLPP2;PLD3;PLD2
KEGG_2019_Mouse,Osteoclast differentiation,10/128,0.1561223781777929,0.460062752715411,0,0,1.4847489219201668,2.7573496482101105,CSF1R;MAPK11;NCF1;PIK3CA;PIK3CD;GRB2;IRF9;JAK1;TNFRSF1A;MAPK3
KEGG_2019_Mouse,Autophagy,10/130,0.1671822886430315,0.4874683574117867,0,0,1.459847778813296,2.611186675593783,IGBP1;BECN1;PPP2CB;PIK3CA;RHEB;ATG2A;PIK3CD;ATG4B;RAF1;MAPK3
KEGG_2019_Mouse,"Glycine, serine and threonine metabolism",4/40,0.1692014093865217,0.4882165666673596,0,0,1.9442899804345588,3.454352934388957,ALAS2;AGXT2;SHMT1;GLYCTK
KEGG_2019_Mouse,Porphyrin and chlorophyll metabolism,4/41,0.1800327807108666,0.5141142294526809,0,0,1.8916414097136989,3.243439250866301,ALAS2;UROD;HMOX1;HMOX2
KEGG_2019_Mouse,Estrogen signaling pathway,10/134,0.1903821539020503,0.5381209860292646,0,0,1.4124552806421549,2.3428704933870725,KCNJ5;PIK3CA;NCOA3;GNAS;PIK3CD;GRB2;CALML4;RAF1;SOS2;MAPK3
KEGG_2019_Mouse,Non-alcoholic fatty liver disease (NAFLD),11/151,0.1959472729551126,0.5482565111976384,0,0,1.376246002132196,2.2431566692081013,NDUFB10;PIK3CA;COX4I2;MLX;PIK3CD;NR1H3;NDUFV3;COX6A1;COX6B2;SDHB;TNFRSF1A
KEGG_2019_Mouse,Basal transcription factors,4/43,0.2023489121697011,0.5557611103977069,0,0,1.7944440483828807,2.86709412341943,TBP;TBPL1;TAF6;GTF2F1
KEGG_2019_Mouse,Inositol phosphate metabolism,6/73,0.2026421377262397,0.5557611103977069,0,0,1.5673720533821145,2.5020175193730263,FIG4;ALDH6A1;PIK3CA;IMPA2;PIK3CD;PIP5K1C
KEGG_2019_Mouse,Bacterial invasion of epithelial cells,6/74,0.2112425895968613,0.573668601160104,0,0,1.544240537440603,2.4009050294706404,PIK3CA;PXN;CTNNA1;CLTA;PIK3CD;HCLS1
KEGG_2019_Mouse,Hedgehog signaling pathway,4/44,0.2138004240133531,0.5749778393368818,0,0,1.7494902687673772,2.6989601514047026,SMURF1;CUL3;BOC;CUL1
KEGG_2019_Mouse,Small cell lung cancer,7/92,0.2305685402068997,0.6141104388203003,0,0,1.4413295429696042,2.114728947921499,ZBTB17;CDKN1B;PIK3CA;COL4A1;MAX;CKS2;PIK3CD
KEGG_2019_Mouse,Cytosolic DNA-sensing pathway,5/61,0.2341293388913184,0.6176554940275732,0,0,1.5621686986482906,2.268083967822383,TBK1;POLR3A;POLR3GL;IKBKE;POLR3K
KEGG_2019_Mouse,Human T-cell leukemia virus 1 infection,16/245,0.2549133679613758,0.6575393247448186,0,0,1.2237223902464978,1.672622340875208,NRP1;RANBP1;MAP3K3;FDPS;TBP;GPS2;PIK3CD;TNFRSF1A;CCNA1;PIK3CA;CDC26;TBPL1;TCF3;MAD1L1;JAK1;MAPK3
KEGG_2019_Mouse,Epstein-Barr virus infection,15/229,0.2600536263793234,0.6575393247448186,0,0,1.227488711540481,1.6532645465398383,CDKN1B;PSMD11;PSMD13;PIK3CD;CCNA1;MAPK11;TBK1;PIK3CA;SIN3A;PSMD2;MDM2;IKBKE;IRF9;JAK1;TLR2
KEGG_2019_Mouse,Tryptophan metabolism,4/48,0.2611759474613565,0.6575393247448186,0,0,1.5901086864942289,2.134817861463188,ALDH3A2;GCDH;DLST;ALDH9A1
KEGG_2019_Mouse,Type II diabetes mellitus,4/48,0.2611759474613565,0.6575393247448186,0,0,1.5901086864942289,2.134817861463188,PIK3CA;PIK3CD;PRKCZ;MAPK3
KEGG_2019_Mouse,Axon guidance,12/180,0.2702402015027156,0.6575393247448186,0,0,1.2504335067360275,1.6361223196717234,NRP1;CAMK2D;PIK3CA;BOC;PIK3CD;CXCR4;RAF1;PRKCZ;WNT4;NCK1;PAK4;MAPK3
KEGG_2019_Mouse,Chemokine signaling pathway,13/197,0.2707964304870268,0.6575393247448186,0,0,1.2369412840308818,1.615925150456932,CCL24;NCF1;PXN;CXCR4;PIK3CD;PRKCZ;PIK3CA;GRK6;CCL2;GRB2;RAF1;SOS2;MAPK3
KEGG_2019_Mouse,Amino sugar and nucleotide sugar metabolism,4/49,0.2733306179574448,0.6575393247448186,0,0,1.5546905571001957,2.016547396430441,CYB5R3;GFPT2;PMM2;GNPNAT1
KEGG_2019_Mouse,Cholesterol metabolism,4/49,0.2733306179574448,0.6575393247448186,0,0,1.5546905571001957,2.016547396430441,STARD3;LRPAP1;NPC1;SOAT1
KEGG_2019_Mouse,Breast cancer,10/147,0.2742655348806918,0.6575393247448186,0,0,1.277542329644016,1.6527035404451915,PIK3CA;NCOA3;ERBB2;ARAF;PIK3CD;GRB2;RAF1;SOS2;WNT4;MAPK3
KEGG_2019_Mouse,JAK-STAT signaling pathway,11/164,0.2756486548981225,0.6575393247448186,0,0,1.2584382011511073,1.621658971206177,PDGFRA;CISH;PIK3CA;IL21R;PIK3CD;GRB2;RAF1;PRLR;SOS2;IRF9;JAK1
KEGG_2019_Mouse,Adrenergic signaling in cardiomyocytes,10/148,0.281155688805365,0.6575393247448186,0,0,1.2682172427299865,1.6091732764988085,PPP2CB;MAPK11;CAMK2D;ACTC1;CREM;GNAS;PPP2R2A;CALML4;RAPGEF4;MAPK3
KEGG_2019_Mouse,Kaposi sarcoma-associated herpesvirus infection,14/216,0.2822888208033449,0.6575393247448186,0,0,1.2133575378117794,1.5346843955880856,BECN1;ANGPT2;PIK3CD;CALML4;TNFRSF1A;C3;MAPK11;TBK1;PIK3CA;RAF1;IKBKE;IRF9;JAK1;MAPK3
KEGG_2019_Mouse,Focal adhesion,13/199,0.2826205689559731,0.6575393247448186,0,0,1.2235101999799016,1.546088696849398,PDGFRA;PXN;PIK3CD;COL1A1;PIK3CA;COL4A1;ERBB2;GRB2;PIP5K1C;RAF1;SOS2;PAK4;MAPK3
KEGG_2019_Mouse,Fatty acid degradation,4/50,0.2855777586993258,0.6575393247448186,0,0,1.5208123463754684,1.905944275147606,ALDH3A2;GCDH;ECI3;ALDH9A1
KEGG_2019_Mouse,Oocyte meiosis,8/116,0.2923095408115706,0.6575393247448186,0,0,1.2960551248923342,1.5940725895469985,PPP2CB;CAMK2D;YWHAQ;CDC26;CUL1;CALML4;MAD1L1;MAPK3
KEGG_2019_Mouse,RNA degradation,6/83,0.2934323109173207,0.6575393247448186,0,0,1.363093730781753,1.6713005281440216,PAN3;MTREX;CNOT10;TOB2;LSM4;CNOT9
KEGG_2019_Mouse,Base excision repair,3/35,0.2940861628974207,0.6575393247448186,0,0,1.6393229166666667,2.0063386025096657,PARP4;NTHL1;POLD2
KEGG_2019_Mouse,DNA replication,3/35,0.2940861628974207,0.6575393247448186,0,0,1.6393229166666667,2.0063386025096657,RFC3;POLD2;MCM5
KEGG_2019_Mouse,Tight junction,11/167,0.2953603767097587,0.6575393247448186,0,0,1.2340401358591655,1.5049848185178345,ACTR3;RAP2C;ACTR2;PPP2CB;ERBB2;HCLS1;PPP2R2A;NF2;PRKCZ;JAM2;JAM3
KEGG_2019_Mouse,Long-term potentiation,5/67,0.2967235219967593,0.6575393247448186,0,0,1.4105422227542044,1.7137445872716546,CAMK2D;ARAF;CALML4;RAF1;MAPK3
KEGG_2019_Mouse,Peroxisome,6/84,0.3029686223651596,0.6649398147138376,0,0,1.3455467466609528,1.606752402016432,ECI3;NUDT19;PXMP4;SOD2;CRAT;PEX14
KEGG_2019_Mouse,Pathways in cancer,32/535,0.3048641027749363,0.6649398147138376,0,0,1.1146215003036015,1.324046804780842,CSF1R;CAMK2D;CDKN1B;MAX;ARAF;CUL1;PIK3CD;CXCR4;CALML4;ERBB2;CTNNA1;HMOX1;JAK1;WNT4;MAPK3;ZBTB17;NQO1;PDGFRA;GSTO1;ZBTB16;NCOA3;NCOA4;PIK3CA;COL4A1;CKS2;MDM2;GNAS;GRB2;ARHGEF1;RAF1;SOS2;FGFR2
KEGG_2019_Mouse,RIG-I-like receptor signaling pathway,5/68,0.3074366230329814,0.6653120670323115,0,0,1.3880790411402657,1.6372202358501529,MAPK11;TBK1;AZI2;IKBKE;TANK
KEGG_2019_Mouse,Gap junction,6/86,0.3222000461760071,0.6908547022706107,0,0,1.3117688022284122,1.4856866057927267,PDGFRA;GNAS;GRB2;RAF1;SOS2;MAPK3
KEGG_2019_Mouse,"Alanine, aspartate and glutamate metabolism",3/37,0.3242278386107559,0.6908547022706107,0,0,1.5427287581699347,1.73758898364354,AGXT2;GFPT2;NIT2
KEGG_2019_Mouse,Mismatch repair,2/22,0.3361274846928797,0.710742849312425,0,0,1.7481036077705827,1.9058957817975095,RFC3;POLD2
KEGG_2019_Mouse,Endocrine and other factor-regulated calcium reabsorption,4/55,0.3476742868237553,0.729254676004833,0,0,1.371349652001672,1.4488160897590705,GNAS;CLTA;AP2B1;RAB11A
KEGG_2019_Mouse,Sulfur relay system,1/8,0.3594637878441413,0.729254676004833,0,0,2.49669923422234,2.554477438736883,CTU1
KEGG_2019_Mouse,"Parathyroid hormone synthesis, secretion and action",7/107,0.3595667982966297,0.729254676004833,0,0,1.2241542750929368,1.2521327007699798,MMP24;ARAF;GNAS;ARHGEF1;RAF1;PLD2;MAPK3
KEGG_2019_Mouse,Hippo signaling pathway,10/159,0.359621160563644,0.729254676004833,0,0,1.1739024374988272,1.2005548750260242,MOB1A;PPP2CB;YWHAQ;ID1;CTNNA1;PPP2R2A;NF2;PRKCZ;TEAD1;WNT4
KEGG_2019_Mouse,Regulation of lipolysis in adipocytes,4/56,0.3601660949591642,0.729254676004833,0,0,1.3449062522278463,1.373404787531498,FABP4;PIK3CA;GNAS;PIK3CD
KEGG_2019_Mouse,Ferroptosis,3/40,0.3693813708320131,0.729254676004833,0,0,1.4174174174174174,1.411642353366921,NCOA4;HMOX1;SLC3A2
KEGG_2019_Mouse,Fat digestion and absorption,3/40,0.3693813708320131,0.729254676004833,0,0,1.4174174174174174,1.411642353366921,DGAT1;PLPP2;SLC27A4
KEGG_2019_Mouse,Tuberculosis,11/178,0.3703175090577695,0.729254676004833,0,0,1.1520801680221646,1.1444701125421262,C3;MAPK11;CAMK2D;CALML4;TLR6;RAF1;ATP6V0A1;JAK1;TNFRSF1A;TLR2;MAPK3
KEGG_2019_Mouse,IL-17 signaling pathway,6/91,0.370888830959143,0.729254676004833,0,0,1.2342782238243486,1.2242224459370157,MAPK11;TBK1;CCL2;ELAVL1;IKBKE;MAPK3
KEGG_2019_Mouse,Thermogenesis,14/231,0.3712090589049872,0.729254676004833,0,0,1.1285796191798183,1.118410974598932,SMARCD2;NDUFB10;ACTL6A;COX4I2;COX6A1;COX6B2;SDHB;MAPK11;RHEB;CNR1;GNAS;GRB2;NDUFV3;SOS2
KEGG_2019_Mouse,Measles,9/144,0.3782576219351033,0.7378687413804481,0,0,1.1658597144630665,1.1334252360474546,TBK1;CDKN1B;PIK3CA;PIK3CD;RCHY1;IKBKE;IRF9;JAK1;TLR2
KEGG_2019_Mouse,Inflammatory mediator regulation of TRP channels,8/127,0.3823289656217359,0.7405952690714744,0,0,1.175563806918116,1.1302738880627614,MAPK11;CAMK2D;PIK3CA;P2RY2;GNAS;PIK3CD;PLA2G4A;CALML4
KEGG_2019_Mouse,Pyrimidine metabolism,4/58,0.3851163123753928,0.7408140175554432,0,0,1.2949576082106202,1.2356613442652504,RRM1;PNP;NME7;NT5M
KEGG_2019_Mouse,Regulation of actin cytoskeleton,13/217,0.3944999971272138,0.7505185544702672,0,0,1.11448140003665,1.0366194341945925,PDGFRA;PXN;ARAF;CXCR4;PIK3CD;PIK3CA;ARHGEF1;PIP5K1C;RAF1;SOS2;FGFR2;PAK4;MAPK3
KEGG_2019_Mouse,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,2/25,0.3955801767244007,0.7505185544702672,0,0,1.5198487712665407,1.4095104708216537,PIGT;PIGX
KEGG_2019_Mouse,Synaptic vesicle cycle,5/77,0.4051752125408183,0.7634934277129706,0,0,1.2139893836322408,1.096761326587905,NAPA;CLTA;AP2B1;ATP6V1E2;ATP6V0A1
KEGG_2019_Mouse,Carbohydrate digestion and absorption,3/43,0.4139581729650523,0.7698711851455069,0,0,1.3109027777777778,1.1562035889683016,PIK3CA;GNAT3;PIK3CD
KEGG_2019_Mouse,Human immunodeficiency virus 1 infection,14/238,0.4141184353309766,0.7698711851455069,0,0,1.092902245088868,0.9635061934868971,PXN;CUL1;CXCR4;PIK3CD;CALML4;TNFRSF1A;MAPK11;TBK1;PIK3CA;AP1S1;RAF1;TLR2;PAK4;MAPK3
KEGG_2019_Mouse,mRNA surveillance pathway,6/96,0.4198034653629145,0.7750415639509131,0,0,1.1653977096874033,1.0115286381397472,PPP2CB;CPSF4;NCBP1;CPSF1;PPP2R2A;UPF3A
KEGG_2019_Mouse,Mineral absorption,3/44,0.4286038570004964,0.7750415639509131,0,0,1.278861788617886,1.0834800941038305,HMOX1;CYBRD1;HMOX2
KEGG_2019_Mouse,Ribosome biogenesis in eukaryotes,7/115,0.4312139219523755,0.7750415639509131,0,0,1.132994286107669,0.9530192465901188,GNL3L;EIF6;TCOF1;UTP4;IMP3;SBDS;NOL6
KEGG_2019_Mouse,NOD-like receptor signaling pathway,12/205,0.4330944202470874,0.7750415639509131,0,0,1.087008896822978,0.9096085167214312,GSDMD;RNF31;MAPK11;TBK1;NAMPT;TRIP6;CCL2;IKBKE;TANK;IRF9;JAK1;MAPK3
KEGG_2019_Mouse,Collecting duct acid secretion,2/27,0.4338335881579654,0.7750415639509131,0,0,1.398112858464385,1.1675560171150383,ATP6V1E2;ATP6V0A1
KEGG_2019_Mouse,Ascorbate and aldarate metabolism,2/27,0.4338335881579654,0.7750415639509131,0,0,1.398112858464385,1.1675560171150383,ALDH3A2;ALDH9A1
KEGG_2019_Mouse,Phosphatidylinositol signaling system,6/98,0.4392637501961057,0.7750415639509131,0,0,1.1399418675063582,0.9377791604034836,PIP4P2;PIK3CA;IMPA2;PIK3CD;CALML4;PIP5K1C
KEGG_2019_Mouse,Oxidative phosphorylation,8/134,0.440524099474319,0.7750415639509131,0,0,1.10984126984127,0.909836914154164,NDUFB10;COX4I2;NDUFV3;COX6A1;COX6B2;ATP6V1E2;SDHB;ATP6V0A1
KEGG_2019_Mouse,Mitophagy,4/63,0.4467528919553115,0.7750415639509131,0,0,1.1849012739353764,0.9547337887064868,BECN1;TBK1;TOMM7;TBC1D17
KEGG_2019_Mouse,Dopaminergic synapse,8/135,0.4488002653775315,0.7750415639509131,0,0,1.1010437648782274,0.8821313075779885,PPP2CB;KCNJ5;MAPK11;CAMK2D;GNAS;PPP2R2A;CALML4;GRIA3
KEGG_2019_Mouse,Circadian entrainment,6/99,0.4489490238406675,0.7750415639509131,0,0,1.12762452451553,0.9030535114031296,KCNJ5;CAMK2D;GNAS;CALML4;GRIA3;MAPK3
KEGG_2019_Mouse,Taurine and hypotaurine metabolism,1/11,0.4580277576451229,0.7750415639509131,0,0,1.7474121996303142,1.3644239878687012,CSAD
KEGG_2019_Mouse,Synthesis and degradation of ketone bodies,1/11,0.4580277576451229,0.7750415639509131,0,0,1.7474121996303142,1.3644239878687012,OXCT1
KEGG_2019_Mouse,Melanogenesis,6/100,0.458597444925693,0.7750415639509131,0,0,1.115569252652166,0.8696782446387803,CAMK2D;GNAS;CALML4;RAF1;WNT4;MAPK3
KEGG_2019_Mouse,Glutathione metabolism,4/64,0.4588693736027067,0.7750415639509131,0,0,1.1650911337658325,0.9075939910471088,RRM1;GSTO1;TXNDC12;LAP3
KEGG_2019_Mouse,cAMP signaling pathway,12/211,0.4730407174367517,0.7917121483629199,0,0,1.0538969356586856,0.7889196453368775,CAMK2D;PIK3CA;BDNF;GNAS;ORAI1;PIK3CD;CALML4;RAF1;GRIA3;RAPGEF4;PLD2;MAPK3
KEGG_2019_Mouse,Alzheimer disease,10/175,0.4770479188491248,0.7917121483629199,0,0,1.0591657488209212,0.7839291731183202,RTN3;NDUFB10;COX4I2;CALML4;NDUFV3;COX6A1;COX6B2;SDHB;TNFRSF1A;MAPK3
KEGG_2019_Mouse,Longevity regulating pathway,6/102,0.4777639097888904,0.7917121483629199,0,0,1.0922121634168989,0.8067500426259061,PIK3CA;RHEB;EIF4EBP2;PIK3CD;SOD2;EIF4E
KEGG_2019_Mouse,Rheumatoid arthritis,5/84,0.4801719888988107,0.7917121483629199,0,0,1.1060097226462506,0.81138082017119,CCL2;TEK;ATP6V1E2;TLR2;ATP6V0A1
KEGG_2019_Mouse,Circadian rhythm,2/30,0.4886494633531366,0.798118740376112,0,0,1.2481168230474429,0.8937888013854771,CUL1;FBXL3
KEGG_2019_Mouse,Vascular smooth muscle contraction,8/140,0.4898201655737871,0.798118740376112,0,0,1.0590556730091614,0.755865999938157,CALCA;ARAF;GNAS;PLA2G4A;ARHGEF1;CALML4;RAF1;MAPK3
KEGG_2019_Mouse,Malaria,3/49,0.4995740169496377,0.8092514777488284,0,0,1.1395531400966183,0.7908493206067677,SDC2;CCL2;TLR2
KEGG_2019_Mouse,Amphetamine addiction,4/68,0.5063328156485832,0.8154313368294044,0,0,1.0920412418906396,0.7432007751473958,CAMK2D;GNAS;CALML4;GRIA3
KEGG_2019_Mouse,Th1 and Th2 cell differentiation,5/87,0.5113606133741057,0.8158777062542658,0,0,1.0653762613692928,0.7145268027761246,ZAP70;MAPK11;MAML1;JAK1;MAPK3
KEGG_2019_Mouse,Arginine and proline metabolism,3/50,0.5132333457375229,0.8158777062542658,0,0,1.1152482269503543,0.7438980830541138,ALDH3A2;LAP3;ALDH9A1
KEGG_2019_Mouse,Amoebiasis,6/106,0.5154462043122617,0.8158777062542658,0,0,1.0483008356545962,0.6947323799984442,COL1A1;PIK3CA;COL4A1;GNAS;PIK3CD;TLR2
KEGG_2019_Mouse,Parkinson disease,8/144,0.5220189224064098,0.8215865994691791,0,0,1.027688098495212,0.6680501302870718,NDUFB10;COX4I2;UBA1;UBE2G1;NDUFV3;COX6A1;COX6B2;SDHB
KEGG_2019_Mouse,SNARE interactions in vesicular transport,2/33,0.5400134205186178,0.8451057484952379,0,0,1.1271522783563606,0.6945075983873024,GOSR1;USE1
KEGG_2019_Mouse,TGF-beta signaling pathway,5/91,0.5516911901267575,0.8495292590945058,0,0,1.0156081460068171,0.6040500349075921,PPP2CB;SMURF1;ID1;CUL1;MAPK3
KEGG_2019_Mouse,Adherens junction,4/72,0.5518441661217457,0.8495292590945058,0,0,1.0275854549419396,0.6108888458429815,PTPN1;ERBB2;CTNNA1;MAPK3
KEGG_2019_Mouse,TNF signaling pathway,6/110,0.5520406737798232,0.8495292590945058,0,0,1.0077673023355476,0.5987483659544529,MAPK11;PIK3CA;PIK3CD;CCL2;TNFRSF1A;MAPK3
KEGG_2019_Mouse,Retrograde endocannabinoid signaling,8/150,0.5688791161773523,0.8706050562493182,0,0,0.983950212905339,0.555033835685775,KCNJ5;GABRA1;MAPK11;NDUFB10;CNR1;NDUFV3;GRIA3;MAPK3
KEGG_2019_Mouse,Gastric acid secretion,4/74,0.5737486916547289,0.8732328988371423,0,0,0.9981199523368198,0.5545193115302399,CAMK2D;KCNE2;GNAS;CALML4
KEGG_2019_Mouse,Glutamatergic synapse,6/114,0.5873222686115667,0.8890069311770707,0,0,0.970236252966058,0.5163418817191056,GNAS;PLA2G4A;DLGAP1;GRIA3;PLD2;MAPK3
KEGG_2019_Mouse,Renin secretion,4/76,0.5950364525500412,0.8909464721965482,0,0,0.970291422098651,0.5037099189222755,ACE;GNAS;ORAI1;CALML4
KEGG_2019_Mouse,Pertussis,4/76,0.5950364525500412,0.8909464721965482,0,0,0.970291422098651,0.5037099189222755,C3;MAPK11;CALML4;MAPK3
KEGG_2019_Mouse,Oxytocin signaling pathway,8/154,0.5989450436730382,0.8919772962227505,0,0,0.9567887862376552,0.4904359931974735,KCNJ5;CAMK2D;EEF2K;GNAS;PLA2G4A;CALML4;RAF1;MAPK3
KEGG_2019_Mouse,Thyroid cancer,2/37,0.6027447410299687,0.8928357928625739,0,0,0.9981234306858728,0.5053114521482909,NCOA4;MAPK3
KEGG_2019_Mouse,Nitrogen metabolism,1/17,0.61201917705293,0.9017516598067106,0,0,1.091786044362292,0.5360578443682419,CAR8
KEGG_2019_Mouse,Cardiac muscle contraction,4/78,0.6156786349830372,0.9023438195254038,0,0,0.9439671367382212,0.4578525200729468,ACTC1;COX4I2;COX6A1;COX6B2
KEGG_2019_Mouse,Cushing syndrome,8/159,0.6349944225561593,0.9257550265687166,0,0,0.924860619128292,0.4200153354427876,MRAP;CAMK2D;CDKN1B;AIP;GNAS;ORAI1;WNT4;MAPK3
KEGG_2019_Mouse,Alcoholism,10/199,0.6412740413138085,0.9300152326907064,0,0,0.923485061416096,0.4103029277053222,HDAC3;BDNF;ARAF;GNAS;GRB2;CALML4;RAF1;SOS2;CAMKK1;MAPK3
KEGG_2019_Mouse,Nicotine addiction,2/40,0.645397682363857,0.931120614660356,0,0,0.9191781488874824,0.4024976239226654,GABRA1;GRIA3
KEGG_2019_Mouse,Aldosterone synthesis and secretion,5/102,0.6532754397345947,0.9327695711674368,0,0,0.8999101046229175,0.3831425152678324,KCNJ5;CAMK2D;GNAS;ORAI1;CALML4
KEGG_2019_Mouse,Th17 cell differentiation,5/102,0.6532754397345947,0.9327695711674368,0,0,0.8999101046229175,0.3831425152678324,ZAP70;MAPK11;IL21R;JAK1;MAPK3
KEGG_2019_Mouse,Homologous recombination,2/41,0.6587857596832295,0.9358136176013055,0,0,0.8955620389477928,0.3737689931543844,ABRAXAS1;POLD2
KEGG_2019_Mouse,Cellular senescence,9/185,0.6765449415720155,0.9561374939563688,0,0,0.8923152615540884,0.348677900250477,CCNA1;MAPK11;PIK3CA;RHEB;MDM2;PIK3CD;CALML4;RAF1;MAPK3
KEGG_2019_Mouse,Nucleotide excision repair,2/43,0.6843412431893461,0.9622463165657305,0,0,0.851785835157149,0.3230811681428679,RFC3;POLD2
KEGG_2019_Mouse,Calcium signaling pathway,9/189,0.7007580092872617,0.9765214114431308,0,0,0.8722998137802607,0.310183410584625,PDGFRA;CAMK2D;STIM1;ERBB2;GNAS;ORAI1;CXCR4;CALML4;TPCN2
KEGG_2019_Mouse,Toxoplasmosis,5/108,0.7020462245090404,0.9765214114431308,0,0,0.8472179692706738,0.2997084655615608,MAPK11;JAK1;TNFRSF1A;TLR2;MAPK3
KEGG_2019_Mouse,Glycosphingolipid biosynthesis,2/45,0.7083053559021328,0.9765214114431308,0,0,0.8120818363702859,0.2800707712389529,B3GNT2;ST6GALNAC6
KEGG_2019_Mouse,Complement and coagulation cascades,4/88,0.7085949592060263,0.9765214114431308,0,0,0.831148770907807,0.2863068147532679,C3;FGG;C5AR1;F3
KEGG_2019_Mouse,Phenylalanine metabolism,1/23,0.7222853064648218,0.9776787103397404,0,0,0.7937741556041001,0.2582425600286943,ALDH1A3
KEGG_2019_Mouse,Protein digestion and absorption,4/90,0.725065468576058,0.9776787103397404,0,0,0.8117335172532707,0.2609669088720249,COL1A1;COL5A1;COL4A1;SLC3A2
KEGG_2019_Mouse,Serotonergic synapse,6/132,0.7259447537403646,0.9776787103397404,0,0,0.8308352124508114,0.266101034961073,KCNJ5;ARAF;GNAS;PLA2G4A;RAF1;MAPK3
KEGG_2019_Mouse,Cortisol synthesis and secretion,3/69,0.7291818030898529,0.9776787103397404,0,0,0.7933922558922559,0.2505788145887168,MRAP;GNAS;ORAI1
KEGG_2019_Mouse,Vitamin digestion and absorption,1/24,0.7373407947639629,0.9776787103397404,0,0,0.7592220525596721,0.2313388204980976,LMBRD1
KEGG_2019_Mouse,Morphine addiction,4/92,0.7408329184968115,0.9776787103397404,0,0,0.793200775128486,0.2379444956109828,KCNJ5;GABRA1;GRK6;GNAS
KEGG_2019_Mouse,Cocaine addiction,2/48,0.741381869166604,0.9776787103397404,0,0,0.7589993162530668,0.2271225329553632,BDNF;GNAS
KEGG_2019_Mouse,ABC transporters,2/48,0.741381869166604,0.9776787103397404,0,0,0.7589993162530668,0.2271225329553632,ABCA2;ABCB6
KEGG_2019_Mouse,Necroptosis,8/176,0.7428699197340269,0.9776787103397404,0,0,0.8305204872646733,0.2468591955785762,RNF31;CAMK2D;PARP4;CHMP1B;PLA2G4A;IRF9;JAK1;TNFRSF1A
KEGG_2019_Mouse,p53 signaling pathway,3/71,0.7468404805123097,0.9776787103397404,0,0,0.7699754901960785,0.2247586663867421,CCNG2;MDM2;RCHY1
KEGG_2019_Mouse,alpha-Linolenic acid metabolism,1/25,0.7515808011311664,0.9776787103397404,0,0,0.7275492914356131,0.2077710207989009,PLA2G4A
KEGG_2019_Mouse,Purine metabolism,6/136,0.7518273898637535,0.9776787103397404,0,0,0.8050996357403043,0.2296534764358135,RRM1;PNP;NME7;NT5M;GART;PDE9A
KEGG_2019_Mouse,Bile secretion,3/72,0.7553185704429763,0.9776787103397404,0,0,0.7587761674718196,0.2129244834660127,GNAS;SLCO1A5;NR0B2
KEGG_2019_Mouse,Thyroid hormone synthesis,3/73,0.7635662922870051,0.983757502155816,0,0,0.7478968253968254,0.2017491558829751,GNAS;SLC26A4;PDIA4
KEGG_2019_Mouse,Phototransduction,1/27,0.7777885098523785,0.991666306088762,0,0,0.6715128679084317,0.1687516067547845,CALML4
KEGG_2019_Mouse,Butanoate metabolism,1/27,0.7777885098523785,0.991666306088762,0,0,0.6715128679084317,0.1687516067547845,OXCT1
KEGG_2019_Mouse,Amyotrophic lateral sclerosis (ALS),2/52,0.7804449629146213,0.991666306088762,0,0,0.6981313598519889,0.1730605204929232,MAPK11;TNFRSF1A
KEGG_2019_Mouse,Protein export,1/28,0.7898374463539598,0.9944771483638494,0,0,0.64660779078524,0.1525529596828858,SPCS2
KEGG_2019_Mouse,Mucin type O-glycan biosynthesis,1/28,0.7898374463539598,0.9944771483638494,0,0,0.64660779078524,0.1525529596828858,GALNT1
KEGG_2019_Mouse,Salivary secretion,3/78,0.8014635189425973,0.9999941875329597,0,0,0.6978518518518518,0.1544456575860245,GNAS;CALML4;AQP5
KEGG_2019_Mouse,Ovarian steroidogenesis,2/57,0.8219211898335711,0.9999941875329597,0,0,0.6344966781599529,0.1244316287137388,GNAS;PLA2G4A
KEGG_2019_Mouse,Pancreatic secretion,4/105,0.826908060298532,0.9999941875329597,0,0,0.6906284697051726,0.1312620643172624,RAB3D;GNAS;TPCN2;RAB11A
KEGG_2019_Mouse,Legionellosis,2/58,0.82932159344873,0.9999941875329597,0,0,0.6231333421435179,0.1166177036416815,C3;TLR2
KEGG_2019_Mouse,Pentose phosphate pathway,1/32,0.8318494445912836,0.9999941875329597,0,0,0.5630552739848548,0.1036606214940032,GLYCTK
KEGG_2019_Mouse,ECM-receptor interaction,3/83,0.8341271699664269,0.9999941875329597,0,0,0.6540625,0.1186269272907296,COL1A1;COL4A1;CD47
KEGG_2019_Mouse,Inflammatory bowel disease (IBD),2/59,0.8364436350134588,0.9999941875329597,0,0,0.6121687196715192,0.1093309720504543,IL21R;TLR2
KEGG_2019_Mouse,MicroRNAs in cancer,12/281,0.8383008895258807,0.9999941875329597,0,0,0.7767329980319265,0.1369987573794369,PDGFRA;MARCKS;HNRNPK;CDKN1B;UBE2I;ERBB2;MDM2;HMOX1;GRB2;RAF1;SOS2;PAK4
KEGG_2019_Mouse,PPAR signaling pathway,3/85,0.8458377870493379,0.9999941875329597,0,0,0.6380420054200542,0.106825891967995,FABP4;NR1H3;SLC27A4
KEGG_2019_Mouse,Prion diseases,1/34,0.8495949549896478,0.9999941875329597,0,0,0.5288746989301518,0.086204231219289,MAPK3
KEGG_2019_Mouse,Pentose and glucuronate interconversions,1/34,0.8495949549896478,0.9999941875329597,0,0,0.5288746989301518,0.086204231219289,AKR1A1
KEGG_2019_Mouse,Insulin secretion,3/86,0.851419242493965,0.9999941875329597,0,0,0.6303212851405623,0.1013875725651083,CAMK2D;GNAS;RAPGEF4
KEGG_2019_Mouse,Hypertrophic cardiomyopathy (HCM),3/86,0.851419242493965,0.9999941875329597,0,0,0.6303212851405623,0.1013875725651083,ACE;ACTC1;LMNA
KEGG_2019_Mouse,Fructose and mannose metabolism,1/35,0.8577531657927573,0.9999941875329597,0,0,0.5132923779493314,0.0787590211564451,PMM2
KEGG_2019_Mouse,Taste transduction,3/88,0.8620552723675434,0.9999941875329597,0,0,0.6154248366013072,0.091351132917038,GABRA1;GNAT3;SCNN1A
KEGG_2019_Mouse,Renin-angiotensin system,1/36,0.8654692423287629,0.9999941875329597,0,0,0.4986004753102719,0.0720395130834695,ACE
KEGG_2019_Mouse,Cholinergic synapse,4/113,0.8670302965785319,0.9999941875329597,0,0,0.6396680582598566,0.0912687076449259,CAMK2D;PIK3CA;PIK3CD;MAPK3
KEGG_2019_Mouse,Wnt signaling pathway,6/160,0.870424745766923,0.9999941875329597,0,0,0.6787613500705423,0.094194409231315,CAMK2D;SFRP2;SOX17;CUL1;TBL1X;WNT4
KEGG_2019_Mouse,Drug metabolism,4/114,0.8714371846600675,0.9999941875329597,0,0,0.6338191928553374,0.0872208059841856,ALDH1A3;RRM1;GSTO1;NME7
KEGG_2019_Mouse,Dilated cardiomyopathy (DCM),3/90,0.8720165313078464,0.9999941875329597,0,0,0.601213282247765,0.0823342936380268,ACTC1;LMNA;GNAS
KEGG_2019_Mouse,Metabolism of xenobiotics by cytochrome P450,2/66,0.8791969706135446,0.9999941875329597,0,0,0.5450104070305273,0.070168085092927,ALDH1A3;GSTO1
KEGG_2019_Mouse,Aminoacyl-tRNA biosynthesis,2/66,0.8791969706135446,0.9999941875329597,0,0,0.5450104070305273,0.070168085092927,TARS2;CARS2
KEGG_2019_Mouse,Tyrosine metabolism,1/40,0.8923720036036371,0.9999941875329597,0,0,0.4473671737997061,0.0509426793414921,ALDH1A3
KEGG_2019_Mouse,Type I diabetes mellitus,2/69,0.8941486005133215,0.9999941875329597,0,0,0.5205241139354109,0.0582379544557052,PRF1;ICA1
KEGG_2019_Mouse,Staphylococcus aureus infection,3/95,0.894183415510719,0.9999941875329597,0,0,0.5683876811594203,0.0635709576179283,C3;FGG;C5AR1
KEGG_2019_Mouse,Herpes simplex virus 1 infection,18/433,0.9032429116503328,0.9999941875329597,0,0,0.7535177329034448,0.0766807951579466,EIF2B4;EIF2B3;SP100;ZFP867;PIK3CD;TNFRSF1A;C3;TBK1;PIK3CA;RHEB;CCL2;EIF2B1;IKBKE;ZFP386;IRF9;JAK1;SRSF9;TLR2
KEGG_2019_Mouse,Ribosome,6/170,0.9035675419007994,0.9999941875329597,0,0,0.6370337658808343,0.0645980369406801,MRPS16;RPS5;MRPS11;MRPL16;MRPL23;MRPL32
KEGG_2019_Mouse,Arrhythmogenic right ventricular cardiomyopathy (ARVC),2/72,0.9073636498898072,0.9999941875329597,0,0,0.4981366459627329,0.0484248457725599,LMNA;CTNNA1
KEGG_2019_Mouse,Intestinal immune network for IgA production,1/43,0.9089583353963374,0.9999941875329597,0,0,0.4153463603556025,0.039647311105188,CXCR4
KEGG_2019_Mouse,Glucagon signaling pathway,3/102,0.9194260303203282,0.9999941875329597,0,0,0.5280022446689113,0.0443551895690081,CAMK2D;GNAS;CALML4
KEGG_2019_Mouse,NF-kappa B signaling pathway,3/102,0.9194260303203282,0.9999941875329597,0,0,0.5280022446689113,0.0443551895690081,ZAP70;UBE2I;TNFRSF1A
KEGG_2019_Mouse,Phagosome,6/180,0.9291394819244592,0.9999941875329597,0,0,0.6001024557359204,0.044105375787633,C3;NCF1;TLR6;ATP6V1E2;ATP6V0A1;TLR2
KEGG_2019_Mouse,Salmonella infection,2/78,0.9292894762359512,0.9999941875329597,0,0,0.4586640050635376,0.0336361197119207,MAPK11;MAPK3
KEGG_2019_Mouse,Sphingolipid metabolism,1/48,0.9311230113621592,0.9999941875329597,0,0,0.3710622566563102,0.0264804431820463,PLPP2
KEGG_2019_Mouse,Notch signaling pathway,1/49,0.9348615642476318,0.9999941875329597,0,0,0.3633125385089341,0.0244715773631102,MAML1
KEGG_2019_Mouse,Cysteine and methionine metabolism,1/50,0.9383973636322258,0.9999941875329597,0,0,0.3558791353879814,0.0226274328343298,AGXT2
KEGG_2019_Mouse,Linoleic acid metabolism,1/50,0.9383973636322258,0.9999941875329597,0,0,0.3558791353879814,0.0226274328343298,PLA2G4A
KEGG_2019_Mouse,Fanconi anemia pathway,1/51,0.9417413957125368,0.9999941875329597,0,0,0.3487430683918669,0.0209331523508977,SLX1B
KEGG_2019_Mouse,Apelin signaling pathway,4/138,0.9451549026177176,0.9999941875329597,0,0,0.5196353727193505,0.0293107850105965,BECN1;CALML4;RAF1;MAPK3
KEGG_2019_Mouse,Viral myocarditis,2/87,0.953194435765174,0.9999941875329597,0,0,0.409903683952767,0.0196492951506042,PRF1;EIF4G2
KEGG_2019_Mouse,Cell adhesion molecules (CAMs),5/170,0.956440020766465,0.9999941875329597,0,0,0.5271265531005791,0.0234767402228725,SPN;PTPRC;SDC2;JAM2;JAM3
KEGG_2019_Mouse,GABAergic synapse,2/90,0.9592806023023388,0.9999941875329597,0,0,0.3958666218148179,0.0164568278736551,GABRA1;TRAK2
KEGG_2019_Mouse,Retinol metabolism,2/91,0.9611351092308636,0.9999941875329597,0,0,0.3913978941679052,0.0155151250760616,DGAT1;ALDH1A1
KEGG_2019_Mouse,Chemical carcinogenesis,2/94,0.9662246430639144,0.9999941875329597,0,0,0.3785745887463299,0.0130074147846632,ALDH1A3;GSTO1
KEGG_2019_Mouse,Hematopoietic cell lineage,2/94,0.9662246430639144,0.9999941875329597,0,0,0.3785745887463299,0.0130074147846632,CSF1R;CD37
KEGG_2019_Mouse,Allograft rejection,1/63,0.9701875644460308,0.9999941875329597,0,0,0.2810655297835549,0.0085066901914252,PRF1
KEGG_2019_Mouse,Basal cell carcinoma,1/63,0.9701875644460308,0.9999941875329597,0,0,0.2810655297835549,0.0085066901914252,WNT4
KEGG_2019_Mouse,Graft-versus-host disease,1/64,0.9718068852081794,0.9999941875329597,0,0,0.27658950209782,0.007909954162714,PRF1
KEGG_2019_Mouse,Cytokine-cytokine receptor interaction,9/292,0.9790790821206452,0.9999941875329597,0,0,0.5517697455435576,0.0116659911695188,CCL24;CSF1R;TNFSF12;IL21R;CXCR4;CCL2;IL16;PRLR;TNFRSF1A
KEGG_2019_Mouse,Adipocytokine signaling pathway,1/71,0.9809308570934868,0.9999941875329597,0,0,0.2488381304462635,0.004790956163941,TNFRSF1A
KEGG_2019_Mouse,Neuroactive ligand-receptor interaction,11/348,0.9832536022131564,0.9999941875329597,0,0,0.5657358607555694,0.0095542626824728,C3;GABRA1;CALCA;P2RY6;CNR1;P2RY2;C5AR1;PPY;GNRH1;PRLR;GRIA3
KEGG_2019_Mouse,Autoimmune thyroid disease,1/78,0.9871036344721515,0.9999941875329597,0,0,0.2261324627313536,0.0029352549033714,PRF1
KEGG_2019_Mouse,Steroid hormone biosynthesis,1/89,0.9930265777390218,0.9999941875329597,0,0,0.1977503780877163,0.0013838275229418,SRD5A3
KEGG_2019_Mouse,Arachidonic acid metabolism,1/89,0.9930265777390218,0.9999941875329597,0,0,0.1977503780877163,0.0013838275229418,PLA2G4A
KEGG_2019_Mouse,cGMP-PKG signaling pathway,3/172,0.9960067111146352,0.9999941875329597,0,0,0.3081525312294543,0.0012330055934969,CALML4;RAF1;MAPK3
KEGG_2019_Mouse,Systemic lupus erythematosus,1/143,0.999658263176148,0.9999941875329597,0,0,0.1221980682616958,4.176671674768975e-05,C3
KEGG_2019_Mouse,Olfactory transduction,3/1133,0.9999941875329597,0.9999941875329597,0,0,0.0437241887905604,2.541461448197057e-07,CAMK2D;CALML4;NCALD
